Register Now - Unlocking Longitudinal Patient-Reported Outcomes: The Untapped Value of Specialty Pharmacyocking
|Articles|July 6, 2015

BioClinica Acquires MediciGroup

BioClinica® announced that it has acquired global patient recruitment and retention firm, MediciGroup. The acquisition includes affiliates MediciGlobal, Ltd. and Access to Patients, LLC.  Medici also provides a lost-to-follow-up patient locate service (L2FU®) that finds missing patients globally. The acquisition adds proprietary technologies and processes to BioClinica’s services as well as the ability to integrate recruitment metrics with BioClinica’s system, to help manage clinical trials in real time.

Liz Moench, founder and CEO of Medici, will lead the company’s global patient recruitment and retention services, headquartered at BioClinica’s Philadelphia-area office.

Read the full release.

 


Related to this article

Where AI Leads in Trial Design—and Where Humans Still Need To
In this video interview, Claire Riches, VP of clinical solutions at Citeline, makes the case for AI as a sophisticated strategic advisor in trial design while arguing that humans must remain in the lead—especially when factors the model can't fully account for are at stake.